Ambroxol

Pharmacologic Category

Mucolytic Agent

Reported Use

Treatment of respiratory tract disorders associated with viscid mucus; relief of sore throat symptoms (lozenge only)

Dosage Range

Oral:

Children 2 to <6 years: 7.5 to 15 mg 3 times daily.

Children 6 to 12 years: 15 to 30 mg 2 to 3 times daily.

Children >12 years, Adolescents, and Adults: 60 to 120 mg/day in 2 to 3 divided doses (immediate release) or 75 mg once daily (extended release capsules; adults only).

Inhalation: Solution for nebulization (7.5 mg/mL):

Children <6 years: 15 mg (2 mL) 1 to 2 times daily.

Children ≥6 years, Adolescents, and Adults: 15 to 22.5 mg (2 to 3 mL) 1 to 2 times daily.

Lozenge:

Children ≥12 years, Adolescents, and Adults: 20 mg (1 lozenge) dissolved in mouth as needed (maximum: 6 lozenges/day).

Product Availability

Product available in various countries; not currently available in the US

Dosage Forms

Capsule Extended Release, Oral, as hydrochloride: 75 mg

Lozenge, Mouth/Throat, as hydrochloride: 20 mg

Solution for Nebulization, Inhalation/Oral: 7.5 mg/mL

Solution, Oral, as hydrochloride: 7.5 mg/mL

Syrup, Oral, as hydrochloride: 3 mg/mL [contains sorbitol]; 6 mg/mL [contains sorbitol]

Tablet, Oral, as hydrochloride: 30 mg [contains lactose]

Anatomic Therapeutic Chemical (ATC) Classification

• R05CB06

Last Updated 3/2/20